Replay available

Stereotaxis, Inc. (STXS) Q2 2025 Earnings Call

Stereotaxis, Inc. (AMEX: STXS) Q2 2025 earnings conference call, held 2025-08-07. Replay captured from the company's public earnings webcast.

Thu, August 7, 2025 at 4:30 PMendedReplay
Stereotaxis, Inc. (STXS) Q2 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Automated Conference System

System Message

David Fishel

Chairman and CEO

Adam Meter

Analyst, Piper Sandler

Frank Takinen

Analyst, Lake Street Capital Markets

Replay transcript excerpt

Please wait. The conference will begin shortly. Good afternoon. Thank you for joining us for StereoTax's second quarter 2025 earnings conference call. Certain statements during the conference call and question and answer period to follow may relate to future events. expectations, and as such constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the company in the future to be materially different from the statements that the company's executives may make to date. These risks are described in detail in our public filings with the Securities and Exchange Commission, including our latest periodic report of Form 10-K or 10-Q. We assume no duty to update these statements. At this time, all participants have been placed on a listen-only mode. The floor will be open for questions and comments following the presentation. As a reminder, today's call is being recorded. It is now my pleasure to turn the floor over to your host, Mr. David Fishel, Chairman and CEO of Astera Texas. Thank you, operator, and good afternoon, everyone. We've described this year as a pivotal, milestone-rich year in which we advance a broad portfolio of strategic innovations to market and demonstrate their initial commercial impact. We're intelligently executing on multiple fronts, and I'm pleased with our results. From both the regulatory and commercial perspective, our results are in line with the guidance provided at the start of this year. I'll keep our prepared remarks brief, providing updates on our key innovation and commercial efforts. As a reminder, our innovation strategy rests on four p...

More from Stereotaxis, Inc.